ERBB3 and breast cancer: Our group and others have shown that ErbB3, a tyrosine kinase receptor which can drive prostate and breast cell proliferation, is key target of NRDP1; decreased NRDP1 expression causes elevation of ErbB3 levels and can thereby increase prostate and breast cancer cell proliferation and survival [7,9,10].